• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND ALINITY I HBSAG QUALITATIVE II CONFIRMATORY REAGENT KIT; TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND ALINITY I HBSAG QUALITATIVE II CONFIRMATORY REAGENT KIT; TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM) Back to Search Results
Model Number 08P1121
Device Problem False Positive Result (1227)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/28/2023
Event Type  malfunction  
Event Description
The customer observed false reactive alinity i hbsag qualitative ii and alinity i hbsag qualitative ii confirmatory results for a pregnant female patient.The sample was pulled and repeated 4 days later with a nonreactive result.A second sample was drawn which generated a nonreactive result.The following data was provided: customer stated they had a sample that was drawn on (b)(6) 2023 that ran on (b)(6) 2023 and gave the following results according to customer: sid (b)(6) hbsag=1.04 hbsag confirmatory = reactive.Repeat of sample on (b)(6) 2023 sample was respun and reran in duplicate according to customer: hbsag=1.19; hbsag=1.27; hbsag confirmatory = 1.11 confirmed positive.Sample was rerun on (b)(6) 2023 result = sid (b)(6) hbsag=0.33 nonreactive.New sample drawn (b)(6) 2023 sid= (b)(6) hbsag = nonreactive hbsag confirmatory = negative.Per alinity i hbsag qualitative ii package insert < 1.00 nonreactive no retest required.= 1.00 reactive retest in duplicate no impact to patient management was reported.
 
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.Complete information for patient identifier: sid (b)(6) and sid (b)(6).
 
Manufacturer Narrative
The complaint investigation included review of data and information provided by the customer, search for similar complaints, ticket and trending review, labeling review, device history review, and in house testing of a retained reagent lot 42595fn00.Return testing was not completed as returns were not available.Data and information provided by the customer was reviewed and support the complaint issue without indication for any additional issue.The lot search review did not identify an increase in complaint activity for the issue of false positive results.The ticket and trending review for the complaint list number did not identify any trends.Device history review in did not identify any nonconformances or deviations associated with the complaint lot and the customer¿s issue.Performance testing was performed using an in-house retained kit of the complaint lot.Acceptance criteria was met indicating the lot is performing as expected.A review of the labeling adequately addresses the customer¿s issue.Based on the investigation, no systemic issue or deficiency with the alinity i hbsag qualitative ii confirmatory reagent, lot 42595fn00, was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY I HBSAG QUALITATIVE II CONFIRMATORY REAGENT KIT
Type of Device
TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM)
Manufacturer (Section D)
ABBOTT IRELAND
finisklin business park
sligo F91VY 44
EI  F91VY44
Manufacturer (Section G)
ABBOTT IRELAND
finisklin business park
sligo F91VY 44
EI   F91VY44
Manufacturer Contact
siobhan wright
lisnamuck
post market surveillance
longford N39 E-932
EI   N39 E932
433331157
MDR Report Key16402194
MDR Text Key310348267
Report Number3008344661-2023-00039
Device Sequence Number1
Product Code LOM
UDI-Device Identifier00380740130459
UDI-Public00380740130459
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 03/23/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/20/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/26/2023
Device Model Number08P1121
Device Catalogue Number08P11-21
Device Lot Number42595FN00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/23/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/16/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALNTY I PROCESSING MODU, 03R65-01, AI21326; ALNTY I PROCESSING MODU, 03R65-01, AI21326
-
-